Department of Surgery and Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. This email address is being protected from spam bots, you need Javascript enabled to view it

Posttransplant malignancy developing in an allograft is an uncommon complication of organ transplantation. The tumor may represent malignant transformation of donor or recipient cells that were previously normal, metastatic malignancy of recipient origin or malignancy transmitted from organ donor to recipient. Establishing the origin of the malignancy is critical to treatment algorithms. It is generally believed allograft removal and immunosuppression withdrawal will lead to resolution of transmitted malignancies in cases where the renal allograft is the origin. We report a male patient who developed metastatic ovarian malignancy secondary to donor transmission.

Written by:
Lipshutz GS, Mihara N, Wong R, Wallace WD, Allen-Auerbach M, Dorigo O, Rao PN, Pham PC, Pham PT   Are you the author?

Reference:
Am J Transplant. 2009 Feb;9(2):428-32
10.1111/j.1600-6143.2008.02507.x

PubMed Abstract
PMID: 19178417

UroToday.com Renal Transplantation and Vascular Disease Section

Please log-in or register in order to submit comments.

Powered by AkoComment!